TY  - GEN
AU  - Ziogas,Dimitrios C
AU  - Papadatos-Pastos,Dionysios
AU  - Thillai,Kiruthikah
AU  - Korantzis,Ippokratis
AU  - Chowdhury,Ruhe
AU  - Suddle,Abid
AU  - O'Grady,John
AU  - Al-Khadimi,Gillian
AU  - Allen,Natalie
AU  - Heaton,Nigel
AU  - Ross,Paul J
AU  - Sarker,Debashis
TI  - Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem
SN  - 1473-5687
PY  - 2017///0724
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Chi-Square Distribution
KW  - Disease Progression
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Liver Neoplasms
KW  - Logistic Models
KW  - London
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Niacinamide
KW  - Odds Ratio
KW  - Patient Selection
KW  - Phenylurea Compounds
KW  - Proportional Hazards Models
KW  - Protein Kinase Inhibitors
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Sorafenib
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1097/MEG.0000000000000739
ER  -